The Charles Koch Institute’s Statement on the Afghanistan Agreement

ARLINGTON, Va.— Following the signing on Saturday of an agreement between the United States and the Taliban, Dr. William Ruger, Afghanistan veteran and vice president of research and policy at the Charles Koch Institute, issued the following statement:

“Ambassador Khalilzad and other members of the Trump administration worked hard to reach this agreement under difficult circumstances and deserve our praise for their efforts. However, this is only a first step toward the ultimate goal of ending our military involvement in the Afghanistan conflict, and President Trump should not allow any flinching from the task of completely withdrawing all U.S. forces from the country. We do not need to wait for the completion of a follow-on deal between the Taliban and Afghan government to feel confident about bringing our troops home. America has achieved what it needed to do in Afghanistan; there is no longer a sound reason for the United States to continue sacrificing precious lives and treasure in a conflict not directly connected to our safety or other vital national interests.”

BACKGROUND: 

New Poll: Americans want troops home from Afghanistan, Iraq; opposed to more military engagement

Public Realism on Afghanistan

War Is the Least Conservative Undertaking – An Interview with Dr. William Ruger

01-07-2021 12:08am

A letter regarding political violence

Violence is never the answer. We must begin the healing process.

Read more

12-02-2020 08:42am

Recidiviz Expansion Will Drive Smart Decarceration

Recidiviz, a non-profit data analytics platform designed to improve state corrections agencies, announces a partnership with the Charles Koch Institute (CKI) to expand its services to 15 states.

Read more

10-09-2020 02:06pm

Charles Koch Institute announces micro-award winners

The Charles Koch Institute (CKI) is proud to announce the recipients of a total of $5,000 in micro awards for the “Re-imagining the Social Safety Net as an Innovation Commons” incubator, funded by CKI.

Read more

Sign up for updates